Nektar Therapeutics (NKTR)
56.77
+0.54
(+0.96%)
USD |
NASDAQ |
Jun 10, 16:00
57.00
+0.23
(+0.41%)
After-Hours: 20:00
Nektar Therapeutics Total Return Price : 56.77 for June 10, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| June 09, 2026 | 56.23 |
| June 08, 2026 | 56.62 |
| June 05, 2026 | 57.32 |
| June 04, 2026 | 59.31 |
| June 03, 2026 | 59.23 |
| June 02, 2026 | 58.56 |
| June 01, 2026 | 63.86 |
| May 29, 2026 | 64.88 |
| May 28, 2026 | 65.01 |
| May 27, 2026 | 65.40 |
| May 26, 2026 | 65.56 |
| May 22, 2026 | 66.61 |
| May 21, 2026 | 68.58 |
| May 20, 2026 | 69.49 |
| May 19, 2026 | 67.58 |
| May 18, 2026 | 68.43 |
| May 15, 2026 | 70.62 |
| May 14, 2026 | 74.33 |
| May 13, 2026 | 75.95 |
| May 12, 2026 | 78.43 |
| May 11, 2026 | 78.72 |
| May 08, 2026 | 81.89 |
| May 07, 2026 | 83.37 |
| May 06, 2026 | 85.09 |
| May 05, 2026 | 84.16 |
| Date | Value |
|---|---|
| May 04, 2026 | 86.89 |
| May 01, 2026 | 86.46 |
| April 30, 2026 | 85.04 |
| April 29, 2026 | 83.20 |
| April 28, 2026 | 83.81 |
| April 27, 2026 | 86.74 |
| April 24, 2026 | 91.68 |
| April 23, 2026 | 91.26 |
| April 22, 2026 | 93.20 |
| April 21, 2026 | 98.16 |
| April 20, 2026 | 100.35 |
| April 17, 2026 | 84.86 |
| April 16, 2026 | 83.99 |
| April 15, 2026 | 83.22 |
| April 14, 2026 | 81.26 |
| April 13, 2026 | 80.45 |
| April 10, 2026 | 77.50 |
| April 09, 2026 | 77.85 |
| April 08, 2026 | 75.08 |
| April 07, 2026 | 76.24 |
| April 06, 2026 | 74.72 |
| April 02, 2026 | 76.99 |
| April 01, 2026 | 75.71 |
| March 31, 2026 | 71.95 |
| March 30, 2026 | 65.25 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Eli Lilly & Co. | 1136.26 |
| Aquestive Therapeutics, Inc. | 3.995 |
| Esperion Therapeutics, Inc. | 3.145 |
| Alumis, Inc. | 20.10 |
| Tvardi Therapeutics, Inc. | 2.70 |